by David Gutierrez, Natural News:
Vaccine industries have their sights set on a new market that they hope will someday be as massive as that created by the just-shy-of-obligatory childhood vaccine schedule: pregnant women.
The industry is working with the FDA to create new rules to test and develop vaccines designed to be given to pregnant women, in order to pass antibodies on to their unborn infants. The fact that this protection would only be short-term is not viewed as a problem.
Indeed, the industry is elated at the possibility to start vaccinating – via their mothers – babies too young to receive traditional vaccines.
Industry senses new opportunity
The concept of maternal vaccination targeting the infant immune system is not a new one. As far back as the 1960s, researchers were working on such a vaccine against respiratory syncytial virus (RSV) – a common and mostly harmless infection that nearly everyone gets by age 2, and that is usually only dangerous for premature infants or babies with other health problems. Companies had soured on the idea of developing an RSV vaccine for newborns after the original RSV vaccine was actually found to increase children’s vulnerability to the disease, and caused two deaths.
But companies also worried that vaccinating pregnant women would not go over well with the public.
“The companies had some concerns about the use of maternal vaccines in a litigious society,” said immunization researcher Ruth Karron of Johns Hopkins University.
In recent years, however, pregnant women seem to have become more accepting of getting vaccines.
Please follow SGT Report on Twitter & help share the message.